Search

Search Results
Results 21 - 30 of 95 for Acromegaly
  • News - 27 Aug 2010
    Much of Sultan Kosen's eight feet, two-inch stature rose up in an 17-year period starting at age 10, when the benign tumor in his brain's pituitary gland highjacked the organ, causing it to secrete...
  • Health - 16 Jun 2023
    Acromegaly is an endocrine disorder where there is a hormonal imbalance in the body. The condition is caused by too much growth hormone (GH).
  • Health - 16 Jun 2023
    Growth hormone is produced and released by the pituitary gland. This is a pea-sized gland just below the brain. Normal release of growth hormone before attainment of puberty allows for normal growth...
  • Health - 16 Jun 2023
    Acromegaly has a slow or gradual onset and the symptoms are also slow to appear. Obvious changes in appearance may not be detected immediately unless present photographs or appearance is compared with...
  • Health - 16 Jun 2023
    Acromegaly has a slow course and symptoms often take months or even years to develop. If the condition is suspected, diagnostic tests are prescribed. The tests are outlined as follows.
  • Health - 16 Jun 2023
    Treatment of Acromegaly aims to reduce excess growth hormone, relieve the pressure that the tumour is exerting on the surrounding structures and thus improve symptoms of the disease. If not treated...
  • Health - 16 Jun 2023
    Acromegaly can cause several complications if left untreated. These complications, like the symptoms of the disease, are gradual in onset and may take months or years to develop.
  • News - 10 Feb 2015
    Chiasma Inc., a U.S. privately-held biopharma company, announced today that results from a multicenter Phase III study of the investigational new drug, octreotide capsules, were published online for...
  • News - 15 Oct 2023
    Researchers delve into endocrine causes of hypertension (HTN), revealing key culprits like primary aldosteronism and Cushing's syndrome. The study also evaluates the efficacy of various treatments,...
  • News - 19 Feb 2013
    Roche and Chiasma Inc., a privately held biopharma company, announced today that they have entered into an agreement to develop and commercialize Chiasma's proprietary product Octreolin, initially for...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.